http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JO-1604-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a910d33c239980f3a705e312c5bad6a
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-04
filingDate 1989-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1990-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca2c44ffa412f4a774ed9a9d11e730ee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b82a5becd671e672620c9a683a1f0fdc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d9556619b6d135c8098a26ccfd6cb16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_74701ae921afb4c90cca99f69a36b162
publicationDate 1990-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JO-1604-B1
titleOfInvention Pyridine derivatives
abstract This invention deals with the innovative derivatives of 3.1-kinonic acid from formula (1) that contains half of the pyridil in the fourth position of the dioxan ring and where the groups in the second, fourth and fifth positions are known vacuum chemistry (CES) and where (X) is hydrogen or coccyx or hydroxy and (J) It is phenylin and (n) is 1 or 2 and p1 is the kylin and for the substitutes (c1) and (c2) in the second mode the dioxane loop is a set of values specified later in this text and (c4) is a hydroxy or retarded ghoul or can sulfonamidopo is acceptable Pharmacistically - With pharmaceutically acceptable salts for these substances. This invention also deals with the processes for making and using acidic derivatives as well as pharmaceutical compositions for therapeutic use in one or more diseases such as ischemic heart disease, cerebrovascular disease, asthma and / or inflammatory diseases.
priorityDate 1989-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393311
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547992
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419571872
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457623688
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10450
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1049

Total number of triples: 21.